171 related articles for article (PubMed ID: 9951556)
41. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha.
Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
Immunology; 2006 Jun; 118(2):261-70. PubMed ID: 16771862
[TBL] [Abstract][Full Text] [Related]
42. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
43. Proanthocyanidins and related compounds: antileishmanial activity and modulatory effects on nitric oxide and tumor necrosis factor-alpha-release in the murine macrophage-like cell line RAW 264.7.
Kolodziej H; Kayser O; Kiderlen AF; Ito H; Hatano T; Yoshida T; Foo LY
Biol Pharm Bull; 2001 Sep; 24(9):1016-21. PubMed ID: 11558561
[TBL] [Abstract][Full Text] [Related]
44. Cyclosporin A inhibits nitric oxide production by L929 cells in response to tumor necrosis factor and interferon-gamma.
Fast DJ; Lynch RC; Leu RW
J Interferon Res; 1993 Jun; 13(3):235-40. PubMed ID: 8366291
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
46. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.
Coutier S; Bezdetnaya L; Marchal S; Melnikova V; Belitchenko I; Merlin JL; Guillemin F
Br J Cancer; 1999 Sep; 81(1):37-42. PubMed ID: 10487610
[TBL] [Abstract][Full Text] [Related]
47. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells.
Cabral GA; Toney DM; Fischer-Stenger K; Harrison MP; Marciano-Cabral F
Life Sci; 1995; 56(23-24):2065-72. PubMed ID: 7776833
[TBL] [Abstract][Full Text] [Related]
48. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
Remels L; Fransen L; Huygen K; De Baetselier P
J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages.
Kiemer AK; Müller C; Vollmar AM
Immunol Cell Biol; 2002 Dec; 80(6):550-7. PubMed ID: 12406389
[TBL] [Abstract][Full Text] [Related]
50. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
51. Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo.
Son EH; Moon EY; Rhee DK; Pyo S
Int Immunopharmacol; 2001 Jan; 1(1):147-54. PubMed ID: 11367512
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.
Männel DN; Falk W; Meltzer MS
Infect Immun; 1981 Jul; 33(1):156-64. PubMed ID: 7021422
[TBL] [Abstract][Full Text] [Related]
53. TPA induction of EL4 resistance to macrophage-released TNF: role of ADP-ribosylation in tumoricidal activities of TNF and other factors.
Fishman M; Essani N; Costlow M
Cell Immunol; 1990 Apr; 127(1):78-91. PubMed ID: 2138520
[TBL] [Abstract][Full Text] [Related]
54. Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation.
Jiang H; Stewart CA; Tan SY; Fast DJ; Rummage JA; Leu RW
Cell Immunol; 1996 Feb; 167(2):293-301. PubMed ID: 8603439
[TBL] [Abstract][Full Text] [Related]
55. TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
Chang NS
Biochem Biophys Res Commun; 2000 Jan; 267(1):194-200. PubMed ID: 10623598
[TBL] [Abstract][Full Text] [Related]
56. Vaccination of brushtail possums, Trichosurus vulpecula, with Bacille Calmette-Guerin induces T lymphocytes that reduce Mycobacterium bovis replication in alveolar macrophages via a contact-dependent/nitric oxide-independent mechanism.
Denis M; Wedlock DN; Buddle BM
Immunol Cell Biol; 2005 Feb; 83(1):57-66. PubMed ID: 15661042
[TBL] [Abstract][Full Text] [Related]
57. Bacteriostatic activity of BCG/PPD-activated macrophages against Mycobacterium fortuitum does not involve reactive nitrogen or oxygen intermediates.
Nibbering PH; Yoshida SI; van den Barselaar MT; van Furth R
Scand J Immunol; 1994 Aug; 40(2):187-94. PubMed ID: 8047840
[TBL] [Abstract][Full Text] [Related]
58. Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.
Guler R; Olleros ML; Vesin D; Parapanov R; Garcia I
Infect Immun; 2005 Jun; 73(6):3668-76. PubMed ID: 15908396
[TBL] [Abstract][Full Text] [Related]
59. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release.
Formica S; Roach TI; Blackwell JM
Immunology; 1994 May; 82(1):42-50. PubMed ID: 8045593
[TBL] [Abstract][Full Text] [Related]
60. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
